Overview of the role and clinical application of dynamic electrocardiography

Ambulatory electrocardiography (Holter monitoring) is an examination technology that records cardiac electrical activity continuously for 24 hours or more. It is mainly used to diagnose arrhythmia, myocardial ischemia and evaluate pacemaker function. Its core value lies in capturing intermittent abnormalities that are difficult to detect on conventional electrocardiograms, such as paroxysmal atrial fibrillation, occult myocardial ischemia, etc. Secondary functions include assessment of drug efficacy and cardiac rehabilitation effects. Structurally, it can be divided into diagnostic applications (primary) and monitoring applications (secondary). The former is directly related to disease diagnosis, while the latter focuses on long-term tracking.

1. Analysis of core diagnostic functions

The most significant advantage of Holter ECG is thatDetect intermittent arrhythmias. When a patient has symptoms such as palpitations and syncope but the ordinary electrocardiogram is normal, key data such as paroxysmal supraventricular tachycardia and long RR interval can be captured through 72 hours of continuous recording. Taking the Peking University People's Hospital study as an example, its diagnostic accuracy for patients with unexplained syncope increased by 67%. At the same time, it can identify asymptomatic myocardial ischemia and determine the coronary blood supply through ST segment changes, which is particularly important for diabetic patients.

2. Expand application scenarios

In postoperative cardiac management, ambulatory electrocardiography canAssess pacemaker working status. For example, Medtronic's CareLink system remotely adjusts parameters through Holter data. Patients taking antiarrhythmic drugs such as amiodarone may be monitored for risk of QT prolongation. The case of Beijing Fuwai Hospital shows that dynamic monitoring has advanced the warning of adverse drug reactions by 3.2 days. In addition, sports enthusiasts can capture exercise-related arrhythmias through portable devices (such as Huawei ECG bracelets).

3. New trends in technological development

The new generation of patch-type dynamic electrocardiograms (such as iRhythm's Zio Patch) achieves 14-day ultra-long monitoring and is only the size of a band-aid. The addition of AI algorithms has increased analysis efficiency by 90%. For example, GE Healthcare's MUSE system can automatically mark 300 types of ECG abnormalities. Among domestic manufacturers, Lepu Medical’s AI-ECG platform has passed NMPA certification, and its accuracy benchmarks against international standards.

Clinical Selection Suggestions and Summary

When selecting Holter ECG equipment, you need to consider the monitoring duration (24/48/72 hours), number of channels (3/12 leads) and analysis software qualifications. For typical symptoms, it is recommended to monitor for at least 3 days; high-risk groups can choose a 7-day event recorder. It should be noted that this examination cannot replace imaging methods such as coronary CTA, but as a "cardiac detective", it has irreplaceable value in capturing transient abnormalities.

Quote sources:
1. "Chinese Journal of Cardiovascular Diseases" 2022 Clinical Application Guidelines for Ambulatory Electrocardiography
2. American College of Cardiology (ACC) Holter Monitoring Expert Consensus
3. Manufacturer’s products:
-Medtronic CareLink™
- Lepu Medical AI-ECG Analysis System
- iRhythm Technologies Zio® XT Patch